logo
AI Icon𝛼SK or Search
bullish

SK Inc

SK Inc: Selling 1.25 Trillion Won Worth of SK Biopharm Through a PRS Contract

404 Views26 Feb 2026 23:27
SK Inc (034730 KS) announced that it plans to sell about 1.25 trillion won worth of its stake (13.94%) in SK Biopharmaceuticals (326030 KS) through a PRS contract.
What is covered in the Full Insight:
  • Introduction to the PRS Contract
  • Financial Impact on SK Inc and SKC
  • Impact on SK Biopharm
  • Mandatory Cancellation of Treasury Shares
  • SK Biopharm Company Background and Financials
Logo
Douglas Kim
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x